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13 as well as components of the innate stress response, including
the chi-lectins Chi3L1 and Chi3L2 and complement component
C3. The major cytokines present were IL-6, GRO, Rantes and
MCP-1. Neither IL-1 nor TNF-α was detectable. Several stress
response proteins, such as the complement components C1r, C1s
and factor H, clusterin, nucleobindin, the chi-lectin Chi3L1 and
EDA-domain containing ﬁbronectin were detectable both in control
media and following activation of TLR2. Peptidoglycan, TNF-α and
IL-1 induced secretion of Chi3L2, the second member of the hu-
man chi-lectin family. Chi3L2 was not detectable in control media.
Both Chi3L1 and Chi3L2 were present in cartilage from asymp-
tomatic individuals. In contrast to Chi3L1, Chi3L2 levels correlated
with the presence of macroscopic signs of damage (Fig. 1).
Figure 1. Expression of Chi3L1 and Chi3L2 in articular cartilage from femoral
heads of patients undergoing joint replacement. Protein levels were determined
by western blotting using speciﬁc antisera. The intensity of bands was deter-
mined densitometrically and normalized to a Chi3L1 or Chi3L2 standard in-
cluded in each blot. Cartilage specimens are grouped into those showing macro-
scopic lesions and lesion-free specimens. The lines represent the mean for each
data set.
Conclusions: The increased production of stress response pro-
teins associated with tissue repair and wound healing by chon-
drocytes suggests that they attempt a repair response similar to
that described in other connective tissues. The induction of the
chi-lectin Chi3L2 is part of this stress response. Its presence in
articular cartilage with early signs of degeneration suggests that
Chi3L2 is produced in response to changes in the matrix environ-
ment and thus could be a useful indicator for the diagnosis and
progression of cartilage erosion.
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Purpose: Our previous study demonstrated that partial inactivation
of Pitx1 gene led to a progressive formation of OA-like lesions in
aging Pitx1+/- mice. To investigate whether Pitx1 plays a role in
human osteoarthritis pathogenesis, we analyzed the expression
level of Pitx1 in knee cartilage of OA patients and age- and gender-
matched control subjects. We observed that Pitx1 mRNA and
protein levels were signiﬁcantly down-regulated in OA patients.
The goals of this study are: 1) to elucidate the mechanisms
responsible for the down-regulation of Pitx1 in osteoarthritis and
2) to identify genes affected by the loss of Pitx1.
Methods: To look for possible mutations, genomic DNA from OA
patients and normal subjects were isolated and 10 kb fragment
upstream of Pitx1 initiation transcription site was sequenced. A
region in Pitx1 promoter, where a SNP was found in the core of an
E2F-response element, was used as bait for DNA pull-down assay
followed by mass spectrometry analysis. The proteins which were
identiﬁed by this method were challenged in different assays either
to conﬁrm their presence in the protein-DNA complex (by EMSA,
ChIP and co-immunoprecipitation), to analyze their expression
level (by RT-PCR and immunohistochemistry) or to determine their
ability to affect the regulation of Pitx1 (by transfection assays
with luciferase). Finally, to identify potential transcriptional targets
of Pitx1, expression level of candidate genes were analysed by
RT-PCR using either mouse model or mRNA isolated from normal
and OA chondrocytes.
Results: No mutation was found in human Pitx1 promoter to
be signiﬁcantly associated with osteoarthritis. Nevertheless, a
SNP, which was found in an E2F-response element caught our
attention since E2F1 was known to up-regulate Pitx1. The mass
spectrometry analysis allowed us to identify a repressor complex
constituted of PHB1, PHB2 and BCoR, which are also known to
act as co-repressors. The presence of BCoR tethered to this E2F
response element was demonstrated by EMSA and ChIP assays.
Since BCoR has never been shown to form a complex with PHB1,
we conﬁrmed this result by co-immunoprecipitation using nuclear
extracts from chondrocytes of OA patients. By transfection assays
using luciferase reporter gene, we were able to show that the
complex formed of PHB1, PHB2 and BCoR is functionally capable
of down-regulating the expression of Pitx1. Using mRNA isolated
from Pitx1+/+, Pitx1-/- mice and OA patients, we were able to
show that knockdown of Pitx1 expression resulted in up-regulation
of PPAR-gamma, Parp1, Extl3 and Reg1B.
Conclusions: We discovered a new complex formed of PHB1,
PHB2 and BCoR which are tethered to an E2F-response element
and able to down-regulate the expression of Pitx1 in chondrocytes
of OA patients. In pre-OA chondrocytes, the nuclear accumulation
of PHB1 could be a primary mechanism leading to OA onset.
The subsequent loss of Pitx1 expression could contribute to the
progression of OA via the up-regulation of PPAR-gamma, Parp1,
Extl3 and Reg1B.
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Purpose: ADAMTS4 and ADAMTS5 are accepted as the main
aggrecanases involved in OA cartilage degradation but the rela-
tive contribution of each enzyme in human disease is still under
debate. Mouse knockout studies have conﬁrmed the importance
of ADAMTS5 in cartilage degradation while ADAMTS4 is generally
associated to OA due to its strong upregulation by IL1β. SiRNA ex-
periments indicate that both aggrecanases participate in cartilage
degradation in human explants. The present study seeks to further
elucidate the role of both aggrecanases in cartilage degradation
using selective pharmacological inhibitors.
Methods: Induction of ADAMTS4 and ADAMTS5 expression by
different cytokines was studied in cartilage explants using RT-
QPCR. Cartilage degradation was induced in human explants
by OSM+TNFα or OSM+ IL1β and the role of individual aggre-
canases was evaluated by pharmacological inhibition using com-
pounds which were synthesised and selected for high selectivity
for ADAMTS4 or ADAMTS5.
